![](/images/graphics-bg.png)
Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
Joint Authors
Lin, Han Chieh
Hou, Ming-Chih
Huang, Yi-Hsiang
Wu, Jaw-Ching
Cheng, Yuan-Lung
Wang, Yuan-Jen
Lan, Keng-Hsin
Huo, Teh-Ia
Su, Chien-Wei
Hsieh, Wei-Yao
Lee, Shou-Dong
Lee, Fa-Yauh
Source
Gastroenterology Research and Practice
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-01-17
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
Background.
Fatty liver index (FLI) and lipid accumulation product (LAP) are indexes originally designed to assess the risk of fatty liver and cardiovascular disease, respectively.
Both indexes have been proven to be reliable markers of subsequent metabolic syndrome; however, their ability to predict metabolic syndrome in subjects without fatty liver disease has not been clarified.
Methods.
We enrolled consecutive subjects who received health check-up services at Taipei Veterans General Hospital from 2002 to 2009.
Fatty liver disease was diagnosed by abdominal ultrasonography.
The ability of the FLI and LAP to predict metabolic syndrome was assessed by analyzing the area under the receiver operating characteristic (AUROC) curve.
Results.
Male sex was strongly associated with metabolic syndrome, and the LAP and FLI were better than other variables to predict metabolic syndrome among the 29,797 subjects.
Both indexes were also better than other variables to detect metabolic syndrome in subjects without fatty liver disease (AUROC: 0.871 and 0.879, resp.), and the predictive power was greater among women.
Conclusion.
Metabolic syndrome increases the cardiovascular disease risk.
The FLI and LAP could be used to recognize the syndrome in both subjects with and without fatty liver disease who require lifestyle modifications and counseling.
American Psychological Association (APA)
Cheng, Yuan-Lung& Wang, Yuan-Jen& Lan, Keng-Hsin& Huo, Teh-Ia& Huang, Yi-Hsiang& Su, Chien-Wei…[et al.]. 2017. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterology Research and Practice،Vol. 2017, no. 2017, pp.1-12.
https://search.emarefa.net/detail/BIM-1156725
Modern Language Association (MLA)
Cheng, Yuan-Lung…[et al.]. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterology Research and Practice No. 2017 (2017), pp.1-12.
https://search.emarefa.net/detail/BIM-1156725
American Medical Association (AMA)
Cheng, Yuan-Lung& Wang, Yuan-Jen& Lan, Keng-Hsin& Huo, Teh-Ia& Huang, Yi-Hsiang& Su, Chien-Wei…[et al.]. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterology Research and Practice. 2017. Vol. 2017, no. 2017, pp.1-12.
https://search.emarefa.net/detail/BIM-1156725
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1156725